Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
International Journal of Cardiology|September 25, 2015
Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart diseaseJ A Eindhoven, A E van den Bosch, R M Oemrawsingh, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 25, 2013
Current discharge management of acute coronary syndromes: data from the Rijnmond Collective Cardiology Research (CCR) studyT Yetgin, M M J M van der Linden, A G de Vries, et al.
Clinical Toxicology (Philadelphia, Pa.)|July 10, 2019
Nicotine intoxication by e-cigarette liquids: a study of case reports and pathophysiologyGerdinique C Maessen, Anjali M Wijnhoven, Rosalie L Neijzen, et al.
European Heart Journal|January 17, 2002
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blockerE Ronner, E Boersma, K M Akkerhuis, et al.
International Journal of Cardiology|July 30, 2018
Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarctionM van Toorenburg, V J van den Berg, T van der Ploeg, et al.
Circulation|April 3, 2002
Coronary flow velocity reserve after percutaneous interventions is predictive of periprocedural outcomeM Albertal, M Voskuil, J J Piek, et al.
European Heart Journal|April 2, 2005
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularizationM J Lenzen, E Boersma, M E Bertrand, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Circulation|June 1, 2000
Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and beta-radiation therapyM Sabaté, J P Marijnissen, S G Carlier, et al.
International Journal of Cardiology|March 9, 2023
Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe diseaseL E Scheffers, R Kok, L E van den Berg, et al.
Pageof 18